Upregulation of CD38 expression on multiple myeloma cells by all-trans retinoic acid improves the efficacy of daratumumab-Reference-Cited by-同舟云学术

Upregulation of CD38 expression on multiple myeloma cells by all-trans retinoic acid improves the efficacy of daratumumab

Published:2015-05-15 Issue:10 Volume:29 Page:2039-2049
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Nijhof I S,Groen R W J,Lokhorst H M,van Kessel B,Bloem A C,van Velzen J,de Jong-Korlaar R,Yuan H,Noort W A,Klein S K,Martens A C M,Doshi P,Sasser K,Mutis T,van de Donk N W C J

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2015123.pdf

Reference39 articles.

1. Kumar SK, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Pandey S et al. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients. Leukemia 2014; 28: 1122–1128.

2. Kumar SK, Lee JH, Lahuerta JJ, Morgan G, Richardson PG, Crowley J et al. Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study. Leukemia 2012; 26: 149–157.

3. van de Donk NW, Lokhorst HM, Dimopoulos M, Cavo M, Morgan G, Einsele H et al. Treatment of relapsed and refractory multiple myeloma in the era of novel agents. Cancer Treat Rev 2010; 37: 266–283.

4. van de Donk NW, Kamps S, Mutis T, Lokhorst HM . Monoclonal antibody-based therapy as a new treatment strategy in multiple myeloma. Leukemia 2012; 26: 199–213.

5. Laubach JP, Tai YT, Richardson PG, Anderson KC . Daratumumab granted breakthrough drug status. Expert Opin Investig Drugs 2014; 23: 445–452.

Cited by 226 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing Fc‐mediated effector functions of monoclonal antibodies: The example of HexaBodies;Immunological Reviews;2024-09-14

2. Antigen escape in CAR-T cell therapy: Mechanisms and overcoming strategies;Biomedicine & Pharmacotherapy;2024-09

3. Functional multiomics reveals genetic and pharmacologic regulation of surface CD38 in multiple myeloma;Blood Neoplasia;2024-09

4. Mechanisms of resistance to daratumumab in patients with multiple myeloma;Basic & Clinical Pharmacology & Toxicology;2024-08-26

5. All-trans retinoic acid in hematologic disorders: not just acute promyelocytic leukemia;Frontiers in Pharmacology;2024-07-04